Moreover, extracellular reducible HMGB1 has been shown to induce autophagy and promote tumor resistance to alkylators, tubulin disrupting agents, DNA cross-linkers, and DNA intercalators in human pancreatic cancer and colon cancer cell lines [31]. Here, HMGB1 is linked to neoplasm.